XSHE
300218
Market cap407mUSD
Oct 09, Last price
12.61CNY
1D
0.40%
1Q
-2.55%
Jan 2017
-22.26%
IPO
33.65%
Name
Anhui Anli Material Technology Co Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Anhui Anli Material Technology Co., Ltd. is a Chinese enterprise dedicated to the innovation, manufacturing, and commercialization of polyurethane synthetic leather and associated resins. These versatile materials are extensively utilized across a broad spectrum of goods, encompassing various footwear categories—from everyday and athletic to safety and fashion shoes—as well as furniture like sofas and massage chairs, and decorative elements for both residential and commercial settings. Their applications also extend to personal accessories such as handbags, luggage, and belts, alongside stationery, diverse packaging (including electronic), sporting equipment, and even interior components for automobiles. Demonstrating a global reach, the company exports its offerings to more than 70 nations and territories internationally. Founded in 1994, the firm, headquartered in Hefei, China, was initially known as Anhui ANLI Artificial Leather Co., Ltd. before officially rebranding to Anhui Anli Material Technology Co., Ltd. in May 2015.
Key people
Chairman of the Board, General Manager
Weiwei Chen
Chief Financial Officer · since 2016
Dongwei Hu
Chief Marketing Officer
Maoxiang Chen
Deputy General Manager, Director
Wanli Huang
Chief Technology Development Officer, Director · since 2024
Songxia Liu
Secretary of the Board, Director of Management · since 2013
Wei Fang
Director · since 2024
Zhongya Li
Director · since 2024
Xinjiang Li
Director · since 2024
Yifeng Wang
Deputy General Manager, Director
Chuguang Yang
Deputy General Manager, Director
Lai Chen
Independent Director · since 2024
Independent Director
Independent Director · since 2024
Qian Zhou
Independent Director · since 2024
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2023‑00 | 2022‑12 | 2022‑00 | 2021‑12 | 2020‑12 | 2020‑00 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | |||||||||||||
Revenues | |||||||||||||
Cost of revenue | |||||||||||||
Unusual Expense (Income) | |||||||||||||
NOPBT | |||||||||||||
NOPBT Margin | |||||||||||||
Operating Taxes | |||||||||||||
Tax Rate | |||||||||||||
NOPAT | |||||||||||||
Net income | |||||||||||||
Dividends | |||||||||||||
Dividend yield | |||||||||||||
Proceeds from repurchase of equity | |||||||||||||
BB yield | |||||||||||||
| Debt | |||||||||||||
Debt current | |||||||||||||
Long-term debt | |||||||||||||
Deferred revenue | |||||||||||||
Other long-term liabilities | |||||||||||||
Net debt | |||||||||||||
| Cash flow | |||||||||||||
Cash from operating activities | |||||||||||||
CAPEX | |||||||||||||
Cash from investing activities | |||||||||||||
Cash from financing activities | |||||||||||||
FCF | |||||||||||||
| Balance | |||||||||||||
Cash | |||||||||||||
Long term investments | |||||||||||||
Excess cash | |||||||||||||
Stockholders' equity | |||||||||||||
Invested Capital | |||||||||||||
ROIC | |||||||||||||
ROCE | |||||||||||||
| EV | |||||||||||||
Common stock shares outstanding | |||||||||||||
Price | |||||||||||||
Market cap | |||||||||||||
EV | |||||||||||||
EBITDA | |||||||||||||
EV/EBITDA | |||||||||||||
Interest | |||||||||||||
Interest/NOPBT | |||||||||||||